Immunotherapy Animation – ValloVax™ Technology MoA

SCIENTIFIC ANIMATION | Utilization of the visual toolkit & consistent brand identity

Batu Biologics’ ValloVax™ technology stimulates the immune system to target multiple apoptotic pathways, slowing the angiogenic process within cancer. The proprietary immunotherapy aims to starve the tumor by training your immune system to target tumor-associated blood vessels. The Mechanism of Action (MoA) animation was created to highlight this less toxic and more effective therapeutic option for the treatment of cancer.

Batu have fully utilized the visual toolkits we provide to solidify their brand identity across multiple platforms. The full animation is the main feature of their website homepage, bringing their science to life.

Several shorter clips of animation reside within their corporate introductory video and within the Batu blog series on YouTube named ‘Starve the Tumor’. Stills from the animation also serve as the backdrop for key website pages such as their therapeutic pipeline, unifying the brand throughout.

Are you interested in seeing how our award-winning medical animation can help you?

Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.


cellectar logo

‘‘Extremely happy, everybody was great on the team. They answered all our questions and made it look easy. The end result is perfect.

Executive Coordinator, Cellectar Biosciences


‘‘The presentation was dramatically enhanced by the video, which looked fantastic on the big screen. Thank you and the entire Random42 team for your excellent work and for getting the final edition to me in time for the conference. All very much appreciated!

President and CEO, Vallum Corporation


‘‘The quality of the work produced by Random42 sets them apart and helps us quickly tell our scientific story more clearly. The high-quality production value is bolstered by their depth of knowledge. Together, that helps us tell the story of a complex disease and cell-based treatment and make it understandable to professionals and laypeople alike.’’

CEO, Brainstorm Cell Therapeutics

Phathom logo

‘‘Working with the Random42 team was a seamless collaboration, where they exhibited great project management skills, clear & thoughtful communication, and delivered high-quality work that was visually appealing. Our team was impressed with the final products!’’

Medical Affairs, Phathom Pharmaceuticals